JPH04503813A - コレステロール吸収を抑制する薬剤、食物製品及び組成物 - Google Patents
コレステロール吸収を抑制する薬剤、食物製品及び組成物Info
- Publication number
- JPH04503813A JPH04503813A JP2506819A JP50681990A JPH04503813A JP H04503813 A JPH04503813 A JP H04503813A JP 2506819 A JP2506819 A JP 2506819A JP 50681990 A JP50681990 A JP 50681990A JP H04503813 A JPH04503813 A JP H04503813A
- Authority
- JP
- Japan
- Prior art keywords
- cholesterol
- sulfated
- effective amount
- absorbable
- absorption
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (18)
- 1.非被吸収性コレステロールエステラーゼ抑制剤を経口投与することを特徴と するコレステロールの腸管吸収を抑制するための方法。
- 2.■臓コレステロールエステラーゼを抑制するための非被吸収性合成硫酸化多 糖類の有効量を経口的に投与することよりなるコレステロールの吸収を減少させ るための請求項1記載の方法。
- 3.非被吸収性多糖類が3−硫酸化非被吸収性多糖類である請求項2記載の方法 。
- 4.3−硫酸化非吸収性多糖類が3−硫酸化アルギン酸、ペクチン、アミロペク チン、キチン、デキストラン、セルロース、寒天又はキトサンである請求項3記 載の方法。
- 5.硫酸化したセルロース、寒天、アミロペクチン、キチン、キトサン、ペクチ ン又はアルギン酸の有効量を経口的に投与することを特徴とするコレステロール 吸収を減少させる方法。
- 6.硫酸デキストラン(分子量200000より大)の有効量を経口投与するこ とを特徴とするコレステロール吸収を減少させる方法。
- 7.■臓コレステロールエステラーゼを分子量が20kDaより大きい合成非被 吸収性硫酸化多糖類の有効抑制量と接触させることを特徴とする■臓コレステロ ールエステラーゼの抑制法。
- 8.非複吸収性合成コレステロールエステラーゼ抑制剤の有効量を含有すること を特徴とする摂取可能な食物製品。
- 9.消化管中で■臓コレステロールエステラーゼを抑制するために20kDaよ り大きい分子量を有する合成非被吸収性3−硫酸化多糖類の有効量を含有する請 求項8記載の摂取可能な食物製品。
- 10.合成3−硫酸化非被吸収性多糖類が3−硫酸化アルギン酸、ペクチン、ア ミロペクチン、キチン、デキストラン、セルロース、寒天又はキトサンである請 求項8記載の摂取可能な食物製品。
- 11.請求項9記載の食品を摂取することを特徴とするコレステロール吸収を低 下させる方法。
- 12.消化管中で■臓コレステロールエステラーゼを抑制するために有効量の硫 酸化セルロース、ペクチン、アルギン酸、寒天、キチン、キトサン、アミロペク チン又はデキストランを含有することを特徴とする摂取可能な食物製品。
- 13.有効量の合成非被吸収性硫酸化多糖類を有効量の被吸収性コレステロール 合成遮断剤と組合わせて投与することを特徴とする血清コレステロールレベルを 低下させる方法。
- 14.有効量の合成非被吸収性硫酸化多糖類を有効量のトリグリセリドリパーゼ 抑制剤と組合わせて投与することを特徴とする血清コレステロールレベルを低下 させる方法。
- 15.有効量の合成非被吸収性硫酸化多糖類を有効量の脂肪アシルコレステロー ル0−アシルトランスフエテーゼ抑制剤と組合わせて投与することを特徴とする 血清コレステロールレベルを低下させる方法。
- 16.コレステロールエステラーゼに対する抗体の有効量を経口投与することよ りなるコレステロールの吸収を減少させる請求項1記載の方法。
- 17.硫酸化イオン交換樹脂の有効量を軽口投与することよりなるコレステロー ルの吸収を減少させる請求項1記載の方法。
- 18.硫酸化セルロース、寒天、アミロペクチン、キチン、キトサン、ペクチン 又はアルギン酸の有効量を経口投与することを特徴とする脂肪酸吸収を減少させ る方法。
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/340,868 US5017565A (en) | 1989-04-20 | 1989-04-20 | Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase |
US429398 | 1989-10-31 | ||
US07/429,398 US5063210A (en) | 1989-04-20 | 1989-10-31 | Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption |
US340868 | 1989-10-31 | ||
PCT/US1990/002079 WO1990012579A1 (en) | 1989-04-20 | 1990-04-20 | The use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04503813A true JPH04503813A (ja) | 1992-07-09 |
JPH0819001B2 JPH0819001B2 (ja) | 1996-02-28 |
Family
ID=26992276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2506819A Expired - Lifetime JPH0819001B2 (ja) | 1989-04-20 | 1990-04-20 | コレステロール吸収を抑制する薬剤、食物製品及び組成物 |
Country Status (10)
Country | Link |
---|---|
US (1) | US5063210A (ja) |
EP (1) | EP0469079B1 (ja) |
JP (1) | JPH0819001B2 (ja) |
AT (1) | ATE114970T1 (ja) |
AU (1) | AU633569B2 (ja) |
CA (1) | CA2053258C (ja) |
DE (1) | DE69014870T2 (ja) |
DK (1) | DK0469079T3 (ja) |
ES (1) | ES2064736T3 (ja) |
WO (1) | WO1990012579A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2008069276A1 (ja) * | 2006-12-06 | 2010-03-25 | 株式会社カネカ | 癌治療剤および発癌抑制剤 |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989008456A1 (en) * | 1988-03-15 | 1989-09-21 | The Jewish Hospital Of St. Louis | Inhibition of intestinal cholesterol and fatty acid absorption |
US5519010A (en) * | 1989-02-06 | 1996-05-21 | Taiho Pharmaceutical Co., Ltd. | Sulfated polysaccharide, pharmaceutically acceptable salt thereof, process for preparing same and medicament containing same as effective component |
US5173408A (en) * | 1989-11-13 | 1992-12-22 | Lange Louis George Iii | Mammalian pancreatic cholesterol esterase |
DE4011285A1 (de) * | 1990-04-06 | 1991-10-10 | Steigerwald Arzneimittelwerk | Arzneimittel zur behandlung von hyperlipidaemie und/oder atherosklerose |
US5616570A (en) * | 1991-10-18 | 1997-04-01 | Lange, Iii; Louis G. | Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion |
CA2098167C (en) * | 1992-06-24 | 2006-12-19 | Dorothea Isler | Foodstuffs and feedstuffs containing a lipase inhibitor |
WO1995003058A1 (fr) * | 1993-07-21 | 1995-02-02 | Belorussky Nauchno-Issledovatelsky Institut Kardiologii | Derives d'amidon oxydes utilises comme agents anti-agregation, anticoagulants et anti-arythmiques |
ATE180808T1 (de) * | 1993-12-23 | 1999-06-15 | Vianova Kunstharz Ag | Wasserverdünnbare lackbindemittel auf der basis von acrylatcopolymerisaten, ein verfahren zu ihrer herstellung und deren verwendung |
AU2453295A (en) * | 1994-09-20 | 1996-04-19 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
CA2160440C (en) * | 1994-10-13 | 1998-08-25 | Louis G. Lange, Iii | Method of manufacturing non-absorbable synthetic sulfated polysaccharides |
US7071174B1 (en) | 1994-10-13 | 2006-07-04 | Cv Therapeutics, Inc. | Method and composition for inhibiting cholesterol esterase |
US5821226A (en) * | 1994-12-01 | 1998-10-13 | Oklahoma Medical Research Foundation | BAL C-tail drug delivery molecules |
US5681819A (en) * | 1994-12-01 | 1997-10-28 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
US5696087A (en) * | 1994-12-01 | 1997-12-09 | Oklahoma Medical Research Foundation | Method and compositions for reducing cholesterol absorption |
US5646130A (en) * | 1995-06-30 | 1997-07-08 | Ocean University Of Oingdao | Low molecular weight sulfated polysaccharides and uses thereof |
US6342218B1 (en) | 1997-02-14 | 2002-01-29 | Oklahoma Medical Research Foundation | Method for treatment of SLE |
US6299868B1 (en) | 1999-07-14 | 2001-10-09 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers |
US6267952B1 (en) | 1998-01-09 | 2001-07-31 | Geltex Pharmaceuticals, Inc. | Lipase inhibiting polymers |
US6264937B1 (en) | 1998-01-09 | 2001-07-24 | Geltex Pharmaceuticals, Inc. | Fat-binding polymers |
US7048917B1 (en) | 1998-01-09 | 2006-05-23 | Genzyme Corporation | Fat-binding polymers |
JPH11349485A (ja) * | 1998-06-09 | 1999-12-21 | Shirako Co Ltd | 肝臓障害改善剤 |
KR20010079636A (ko) * | 1998-08-14 | 2001-08-22 | 프리돌린 클라우스너, 롤란드 비. 보레르 | 라이페이즈 저해제 및 키토산을 포함하는 약학 조성물 |
US6462029B1 (en) * | 1999-02-23 | 2002-10-08 | Econugenics | Compositions and methods for treating mammals with modified alginates and modified pectins |
AU774958B2 (en) * | 1999-10-02 | 2004-07-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Fibroblast growth factor-5 (FGF-5) is a tumor associated T-cell antigen |
JP4601100B2 (ja) * | 1999-11-08 | 2010-12-22 | 三生医薬株式会社 | マスティックの油液を内包した軟カプセル |
JP4265911B2 (ja) * | 2000-07-28 | 2009-05-20 | エフ.ホフマン−ラ ロシュ アーゲー | 新規医薬組成物 |
KR100556324B1 (ko) * | 2000-07-28 | 2006-03-03 | 에프. 호프만-라 로슈 아게 | 리파제 억제제 및 담즙산 격리제를 포함하는 약학 조성물 |
US7041280B2 (en) * | 2001-06-29 | 2006-05-09 | Genzyme Corporation | Aryl boronate functionalized polymers for treating obesity |
US7049345B2 (en) * | 2001-06-29 | 2006-05-23 | Genzyme Corporation | Fat-binding polymers |
US6949261B2 (en) | 2002-11-12 | 2005-09-27 | Ayurvedic-Life International, Llc | Compositions for diabetes treatment and prophylaxis |
US6946151B2 (en) * | 2002-11-12 | 2005-09-20 | Ayurvedic-Life International, Llc | Therapeutic compositions |
ES2251289B1 (es) | 2004-02-27 | 2007-07-01 | Bioiberica, S.A. | Nuevo uso terapeutico de un grupo de polisacaridos sulfatados. |
DE102007035322B4 (de) * | 2007-07-25 | 2011-11-17 | Friedrich-Schiller-Universität Jena | Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate |
US20100324075A1 (en) * | 2007-12-21 | 2010-12-23 | University Of Cincinnati | Therapeutic use of carboxyl ester lipase inhibitors |
US8022347B2 (en) * | 2008-06-23 | 2011-09-20 | Ricoh Company, Ltd. | Optical scanning device, image forming apparatus, and optical scanning method having a plurality of light intensity control devices with a switching unit |
GB0920633D0 (en) | 2009-11-25 | 2010-01-13 | Rdbiomed Ltd | Inhibition of pancreatic lipase |
EP2844303B1 (en) | 2012-05-03 | 2021-09-15 | Beth Israel Deaconess Medical Center, Inc. | Lipids that increase insulin sensitivity and methods of using the same |
US10604473B2 (en) | 2013-03-15 | 2020-03-31 | Beth Israel Deaconess Medical Center, Inc. | Lipids that increase insulin sensitivity and methods of using the same |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB896876A (en) * | 1958-08-18 | 1962-05-23 | Riker Laboratories Inc | Orally administrable hormonal and anti-coagulant medicines comprising chelating agents |
GB871590A (en) * | 1958-08-18 | 1961-06-28 | Riker Laboratories Inc | Water soluble antilipemic salts of sulphated polysaccharides |
US3148114A (en) * | 1959-11-20 | 1964-09-08 | American Cyanamid Co | Method of reducing cholesterol levels |
GB953626A (en) * | 1961-04-25 | 1964-03-25 | Meito Sangyo Kk | Enteric-coated tablets of dextran sulphate ester and method of preparation thereof |
US3175942A (en) * | 1962-03-13 | 1965-03-30 | Evans Medical Ltd | Gastro-intestinal therapeutic |
GB1053143A (ja) * | 1963-03-29 | 1900-01-01 | ||
US3511910A (en) * | 1966-04-08 | 1970-05-12 | Frank E Halleck | Animal food products for reducing plasma cholesterol levels |
ES343957A1 (es) * | 1967-08-09 | 1968-10-01 | Rocador Sa | Procedimiento de obtencion de polisacaridos sulfatados an- tilipemicos activos por via oral. |
US3637657A (en) * | 1968-04-01 | 1972-01-25 | Meito Sangyo Kk | Aluminum complex of sulfated polysaccharide and process for the preparation thereof |
US3627872A (en) * | 1968-04-08 | 1971-12-14 | Upjohn Co | Oral treatment of hyper-cholesteremia in mammals and birds with ether-type anion exchangers of polysaccharides |
DE2037942C2 (de) * | 1970-04-15 | 1982-11-18 | Biomed Research, Inc., 90048 Los Angeles, Calif. | Arzneimittel enthaltend ein "aktives" Chondroitinsulfat als Wirkstoff zur Verhinderung des Auftretens atherosklerotischer Läsionen und zur Verhinderung des Auftretens von Herzanfällen |
FR2192813B1 (ja) * | 1972-07-20 | 1975-08-08 | Centre Etd Ind Pharma | |
JPS5027884A (ja) * | 1973-07-12 | 1975-03-22 | ||
IT1052819B (it) * | 1975-12-12 | 1981-07-20 | Fargal Pharmasint Lab Biochim | Preparato inibitore dell assorbimento dei lipidi a base di dietilamminoetildestrano |
JPS52139715A (en) * | 1976-05-14 | 1977-11-21 | Nippon Kayaku Co Ltd | Coated granules of alkali polyacrylate |
US4066829A (en) * | 1976-07-12 | 1978-01-03 | American Cyanamid Company | Malto-dextrin poly(H-)sulfates |
JPS5515435A (en) * | 1978-07-20 | 1980-02-02 | Seikagaku Kogyo Co Ltd | Blood platelet coagulation suppressing agent |
US4220017A (en) * | 1978-08-07 | 1980-09-02 | Harold Freeman Jewelry Mfg. Co., Inc. | Convertible finger ring |
US4223023A (en) * | 1978-10-12 | 1980-09-16 | Ivan Furda | Nonabsorbable lipid binder |
US4302577A (en) * | 1979-10-05 | 1981-11-24 | Biomed Research Inc. | Process for preparing CSA or CSC |
US4411911A (en) * | 1980-01-31 | 1983-10-25 | Taiho Pharmaceutical Company, Limited | Method of treating hyperlipidemia and inflammation with sulfonate derivatives |
IT1140999B (it) * | 1980-06-18 | 1986-10-10 | Italfarmaco Spa | Glicosaminoglicani modificati dotati di attivita' antilipemica e privi di attivita' anticoagulante |
JPS5790002A (en) * | 1980-11-27 | 1982-06-04 | Asahi Chem Ind Co Ltd | Cellulose sulfate containing heparin-like property and its production |
IT1144697B (it) * | 1981-04-06 | 1986-10-29 | Texcontor Ets | Derivato semi-sintetico della chitina processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo |
US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
FR2538404B1 (ja) * | 1982-12-28 | 1985-08-23 | Anic Spa | |
FR2555993B1 (fr) * | 1983-12-06 | 1986-11-07 | Anic Spa | Chitosanes 6-sulfates et procede pour leur preparation |
US4520017A (en) * | 1983-02-04 | 1985-05-28 | Tunc Deger C | Method of reducing nutrient absorption |
US4623539A (en) * | 1983-02-04 | 1986-11-18 | Tunc Deger C | Nutrient barrier polysaccharide compositions and method of use |
FR2543145B1 (fr) * | 1983-03-24 | 1986-10-17 | Sanofi Sa | Nouveaux sulfates de xylanes, leur procede de preparation et leur activite anti-thrombotique et hypolipemiante |
CA1247547A (en) * | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
FR2572731B1 (fr) * | 1984-11-07 | 1987-03-06 | Sanofi Sa | Nouveaux sulfates de xylanes de bas poids moleculaires, leur procede de preparation et leur activite antithrombotique et hypolipemiante par voie orale |
FR2574663B1 (fr) * | 1984-12-17 | 1987-01-16 | Sanofi Sa | Nouvelle composition therapeutique a activite antithrombotique et hypolipemiante a base de xylanes et d'un acide organique |
US4883788A (en) * | 1986-06-06 | 1989-11-28 | Hauser-Kuhrts, Inc. | Method and composition for reducing serum cholesterol |
DE3634392A1 (de) * | 1986-10-09 | 1988-04-14 | Knoll Ag | Verwendung polysulfatierter niedermolekularer dextransulfate |
DE3705669A1 (de) * | 1987-02-21 | 1988-09-01 | Thomae Gmbh Dr K | Verwendung von dextransulfat zur herstellung eines arzneimittels zur behandlung und prophylaxe von gefaessverengungen und gefaessverschluessen |
-
1989
- 1989-10-31 US US07/429,398 patent/US5063210A/en not_active Expired - Lifetime
-
1990
- 1990-04-20 AU AU55356/90A patent/AU633569B2/en not_active Expired
- 1990-04-20 EP EP90907923A patent/EP0469079B1/en not_active Expired - Lifetime
- 1990-04-20 ES ES90907923T patent/ES2064736T3/es not_active Expired - Lifetime
- 1990-04-20 WO PCT/US1990/002079 patent/WO1990012579A1/en active IP Right Grant
- 1990-04-20 DE DE69014870T patent/DE69014870T2/de not_active Expired - Lifetime
- 1990-04-20 JP JP2506819A patent/JPH0819001B2/ja not_active Expired - Lifetime
- 1990-04-20 CA CA002053258A patent/CA2053258C/en not_active Expired - Lifetime
- 1990-04-20 AT AT90907923T patent/ATE114970T1/de not_active IP Right Cessation
- 1990-04-20 DK DK90907923.8T patent/DK0469079T3/da active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2008069276A1 (ja) * | 2006-12-06 | 2010-03-25 | 株式会社カネカ | 癌治療剤および発癌抑制剤 |
Also Published As
Publication number | Publication date |
---|---|
DE69014870T2 (de) | 1995-04-27 |
WO1990012579A1 (en) | 1990-11-01 |
DE69014870D1 (de) | 1995-01-19 |
AU5535690A (en) | 1990-11-16 |
DK0469079T3 (da) | 1995-07-10 |
AU633569B2 (en) | 1993-02-04 |
CA2053258A1 (en) | 1990-10-21 |
ES2064736T3 (es) | 1995-02-01 |
EP0469079B1 (en) | 1994-12-07 |
CA2053258C (en) | 1998-02-10 |
JPH0819001B2 (ja) | 1996-02-28 |
US5063210A (en) | 1991-11-05 |
ATE114970T1 (de) | 1994-12-15 |
EP0469079A1 (en) | 1992-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04503813A (ja) | コレステロール吸収を抑制する薬剤、食物製品及び組成物 | |
CA2132150C (en) | Antiulcer agent and adhesion inhibitor for helicobacter pyroli | |
US5017565A (en) | Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase | |
Sánchez-Machado et al. | Chitosan | |
JP2002522492A (ja) | リパーゼ阻害剤とキトサンを含む製薬学的組成物 | |
US20100256090A1 (en) | Alginic Acid with Low Molecular Weight, Its Salts, Uses, Preparative Methods, Pharmaceutical Compositions and Foods | |
JPH0672893A (ja) | 抗リウマチ剤 | |
PT1373543E (pt) | Processo para a preparação de produtos de hidrólise da pectina | |
BG64458B1 (bg) | Използване на цинков хиалуронат срещу пептична язва | |
JP7270145B2 (ja) | 低分子ナマコ由来グリコサミノグリカン及びその応用 | |
US5484777A (en) | Pancreatic cholesterol esterase inhibitor | |
JP2003508444A (ja) | 植物抽出物混合物及びそれらの使用 | |
JP2002223727A (ja) | 機能性食品 | |
JP2007126453A (ja) | ヒアルロナン産生促進剤及びヒアルロナン分解抑制剤 | |
US5616570A (en) | Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion | |
WO2020250980A1 (ja) | 経口剤、癌抑制補助剤及びペット療法食 | |
JPH0930987A (ja) | 難治性の潰瘍、胃炎及び皮膚炎の治療乃至予防用製剤 | |
ES2290195T3 (es) | Uso de hidratos de carbono para eliminar infecciones intestinales en animales. | |
JP3884611B2 (ja) | 衝動性疾患の改善剤 | |
JP2003048839A (ja) | 免疫反応性NO合成を誘導するiNOS酵素を刺激する組成剤およびその製造方法 | |
JP4001443B2 (ja) | リン吸収阻害剤及びそれを含む治療剤 | |
JP2006206474A (ja) | 機能性食品及び医薬 | |
JP2009057285A (ja) | 血管新生阻害剤及びその利用 | |
JPH1067804A (ja) | キトサン誘導体およびその製造法並びにその用途 | |
AU682792B2 (en) | Method of manufacturing non-absorbable synthetic sulfated polysaccharides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090228 Year of fee payment: 13 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100228 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100228 Year of fee payment: 14 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110228 Year of fee payment: 15 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110228 Year of fee payment: 15 |